Picture of Viatris logo

VTRS — Viatris News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Viatris falls on downbeat 2026 profit forecast

** Shares of Viagra and Xanax maker Viatris VTRS.O fall 3.6% to $15.5 premarket

** Co expects 2026 adjusted profit in the range of $2.33 and $2.47 per share, below analysts' average estimate of $2.49 per share, according to data compiled by LSEG

** Co posted Q4 revenue of $3.70 billion, beating estimates of $3.53 billion

** Co reports Q4 adjusted profit of 57 cents vs. estimates of 53 cents

** VTRS said in its earnings release that it expects regulatory decisions for six products this year

** VTRS stock was up 29.2% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))

Recent news on Viatris

See all news